XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Unaudited Consolidated Statements of Changes in Stockholders Equity - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Earnings
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Treasury Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive Loss
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Earnings
Total
Beginning Balances at Dec. 31, 2021                 $ 10 $ (23,559) $ 109,538 $ (2,462) $ 13,744 $ 97,271
Beginning Balances (In Shares) at Dec. 31, 2021                 101,952,683 4,414,767        
Net income (loss)                         494 494
Stock-based compensation, net                     560     560
Cancelled common stock (in shares)                 (5,015,898) 5,015,898        
Cumulative translation adjustment                       (18)   (18)
Ending Balances at Mar. 31, 2022                 $ 10 $ (23,559) 110,098 (2,480) 14,238 98,307
Ending Balances (In shares) at Mar. 31, 2022                 96,936,785 9,430,665        
Beginning Balances at Dec. 31, 2022 $ (268) $ (268) $ 10 $ (23,559) $ 139,287 $ (2,574) $ 87,415 $ 200,579 $ 10 $ (23,559) 139,287 (2,574) 87,683 200,847
Beginning Balances (In Shares) at Dec. 31, 2022     100,316,701 9,430,665         100,316,701 9,430,665        
Net income (loss)                         43,825 43,825
Stock-based compensation, net                     2,112     2,112
Stock-based compensation, net (in shares)                 643,662          
Tax withholdings related to net share settlement of equity awards                     (6,177)     (6,177)
Cumulative translation adjustment                       (21)   (21)
Issuance of Common Stock from exercise of warrants                     42     42
Issuance of Common Stock from exercise of warrants (in shares)                 2,869          
Issuance of Common Stock from exercise of stock options                     1,252     1,252
Issuance of Common Stock from exercise of stock options (in shares)                 410,226          
Ending Balances at Mar. 31, 2023                 $ 10 $ (23,559) $ 136,516 $ (2,595) $ 131,240 $ 241,612
Ending Balances (In shares) at Mar. 31, 2023                 101,373,458 9,430,665